Temporal trends and clinical predictors of GLP-1 receptor agonist and SGLT2 inhibitor use after myocardial infarction among patients with type 2 diabetes
Patients with myocardial infarction (MI) are at high risk of adverse outcomes, including mortality. Individuals with type 2 diabetes (T2D) are particularly vulnerable due to accelerated atherosclerosis, endothelial dysfunction, chronic inflammation and enhanced platelet activity, all of which contribute to an ele...